Literature DB >> 15699795

Surgical treatment of cervical myeloradiculopathy associated with movement disorders: indications, technique, and clinical outcome.

Albert S Wong1, Eric M Massicotte, Michael G Fehlings.   

Abstract

OBJECTIVE: Movement disorders may be associated with advanced cervical myeloradiculopathy, which represents a major management challenge. We report on eight patients with movement disorders causing progressive cervical myeloradiculopathy who were treated successfully by cervical decompression and reconstruction.
RESULTS: The mean age of our patients was 44 years with a male/female ratio of 3:1. The average duration of symptoms prior to presentation was 10 months. The most common levels decompressed and reconstructed were C3-C4 and C4-C5. Six cases showed improvement, and two cases showed stabilization of neurologic status at a mean follow-up of 21 months. Our management strategy and results are interpreted in the context of a systematic review of the literature in which 78 cases are reported.
CONCLUSIONS: Movement disorders cause premature cervical spondylosis most commonly involving the C3-C4 and C4-C5 levels. Ventral pathology with kyphotic angulation requires corpectomy or discectomy with or without posterior decompression and reconstruction. Decompression should always be combined with segmental internal fixation. Perioperative use of botulinum toxin and halo vest immobilization can increase the rate of clinical success but requires vigilance to minimize complications. Laminectomy with lateral mass fixation may be used successfully in the absence of kyphotic deformity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699795     DOI: 10.1097/01.bsd.0000128693.44276.86

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  8 in total

1.  Clinical Findings and Natural History in Ten Unrelated Families with Juvenile and Adult GM1 Gangliosidosis.

Authors:  João Stein Kannebley; Laura Silveira-Moriyama; Laís Orrico Donnabella Bastos; Carlos Eduardo Steiner
Journal:  JIMD Rep       Date:  2015-06-25

2.  Long-term surgical outcomes of cervical myelopathy with athetoid cerebral palsy.

Authors:  Keung Nyun Kim; Poong Gee Ahn; Mi Jung Ryu; Dong Ah Shin; Seong Yi; Do Heum Yoon; Yoon Ha
Journal:  Eur Spine J       Date:  2013-12-15       Impact factor: 3.134

3.  Current and future medical treatment in primary dystonia.

Authors:  Cathérine C S Delnooz; Bart P C van de Warrenburg
Journal:  Ther Adv Neurol Disord       Date:  2012-07       Impact factor: 6.570

4.  Surgical treatments for cervical spondylotic myelopathy associated with athetoid cerebral palsy.

Authors:  Yong-Jeon Lee; Dong-Sup Chung; Jong-Tae Kim; Ho-Jin Bong; Young-Min Han; Young-Sup Park
Journal:  J Korean Neurosurg Soc       Date:  2008-06-20

5.  Cervical myelopathy in athetoid and dystonic cerebral palsy: retrospective study and literature review.

Authors:  Raphael Jameson; Celia Rech; Christian Garreau de Loubresse
Journal:  Eur Spine J       Date:  2010-01-12       Impact factor: 3.134

6.  Comparison of Morphological Characteristics of the Subaxial Cervical Spine between Athetoid Cerebral Palsy and Normal Control.

Authors:  Jun Young Kim; Jae Yeol Kwon; Moon Seok Kim; Jeong Jae Lee; Il Sup Kim; Jae Taek Hong
Journal:  J Korean Neurosurg Soc       Date:  2018-02-28

7.  Multiple neck operations in a patient with severe motor tics because of Tourette's syndrome: a case report.

Authors:  Tomohiro Miyashita; Masashi Yamazaki; Akihiko Okawa; Minori Yoneda; Atsuomi Aiba; Masao Koda; Kazuhisa Takahashi
Journal:  J Med Case Rep       Date:  2012-07-30

8.  Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.

Authors:  You Gyoung Yi; Keewon Kim; Youbin Yi; Young-Ah Choi; Ja-Ho Leigh; Moon Suk Bang
Journal:  Toxins (Basel)       Date:  2018-05-16       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.